Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01705301 · ClinicalTrials.gov registry record
Neurotransmitter Measurements Using (WINCS) During Deep Brain Stimulation Neurosurgery
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 36
- Enrollment target
NCT01705301: Completed study, sponsored by Mayo Clinic.
NCT01705301 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01705301 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
In this study, the investigators will monitor extracellular neurotransmitter levels using a probe that is able to perform real time electrochemical detection during deep brain stimulation surgery. The overall question this study is designed to answer is: Are there neurotransmitters released during deep brain stimulation?
Interventions
- DEVICE WINCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2010-01 |
| Est. Completion | 2017-07-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01705301
The ClinicalTrials.gov registry entry for NCT01705301 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which WINCS is the first listed.
NCT01705301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01705301 about?
NCT01705301 is a clinical study titled "Neurotransmitter Measurements Using (WINCS) During Deep Brain Stimulation Neurosurgery". In this study, the investigators will monitor extracellular neurotransmitter levels using a probe that is able to perform real time electrochemical detection during deep brain stimulation surgery. The overall question this study is designed to answer is: Are there neurotransmitters released during d...
What is the current status of trial NCT01705301?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2010-01. Estimated completion is 2017-07-27.
What interventions are being tested in trial NCT01705301?
The interventions under investigation include: WINCS (DEVICE).
Who is sponsoring clinical trial NCT01705301?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.